Related Experiment Video
Updated: Oct 22, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Initial antimicrobial management of sepsis
Michael S Niederman1, Rebecca M Baron2, Lila Bouadma3
1Pulmonary and Critical Care Medicine, New York Presbyterian/Weill Cornell Medical Center, 425 East 61st St, New York, NY, 10065, USA. msn9004@med.cornell.edu.
Abstract:
Sepsis is a common consequence of infection, associated with a mortality rate > 25%. Although community-acquired sepsis is more common, hospital-acquired infection is more lethal. The most common site of infection is the lung, followed by abdominal infection, catheter-associated blood steam infection and urinary tract infection. Gram-negative sepsis is more common than gram-positive infection, but sepsis can also be due to fungal and viral pathogens. To reduce mortality, it is necessary to give immediate, empiric, broad-spectrum therapy to those with severe sepsis and/or shock, but this approach can drive antimicrobial overuse and resistance and should be accompanied by a commitment to de-escalation and antimicrobial stewardship. Biomarkers such a procalcitonin can provide decision support for antibiotic use, and may identify patients with a low likelihood of infection, and in some settings, can guide duration of antibiotic therapy. Sepsis can involve drug-resistant pathogens, and this often necessitates consideration of newer antimicrobial agents.
Insights
Sepsis, a severe infection response, has a high mortality rate. Prompt treatment with broad-spectrum antibiotics is crucial but requires careful antimicrobial stewardship and de-escalation to combat resistance.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
- It is a common complication of infections, particularly hospital-acquired infections, with a mortality rate exceeding 25%.
- Common infection sites include the lungs, abdomen, and bloodstream, with Gram-negative pathogens being frequent culprits.
Purpose of the Study:
- To review the epidemiology, clinical presentation, and management strategies for sepsis.
- To highlight the challenges posed by antimicrobial resistance in sepsis treatment.
- To discuss the role of biomarkers and antimicrobial stewardship in optimizing sepsis care.
Main Methods:
- Literature review of sepsis epidemiology, risk factors, and treatment guidelines.
- Analysis of current therapeutic approaches, including empiric broad-spectrum antibiotic therapy.
- Evaluation of diagnostic and prognostic biomarkers, such as procalcitonin.
Main Results:
- Hospital-acquired sepsis is more lethal than community-acquired sepsis.
- Effective management necessitates immediate, empiric, broad-spectrum antibiotic therapy for severe sepsis and shock.
- Antimicrobial stewardship, de-escalation, and the use of biomarkers like procalcitonin are essential to mitigate resistance and guide therapy.
Conclusions:
- Sepsis management requires a balance between rapid intervention and judicious antibiotic use.
- Antimicrobial stewardship programs are critical to combat the rise of drug-resistant pathogens in sepsis.
- Biomarkers can aid in decision-making for antibiotic initiation and duration, improving patient outcomes and reducing resistance pressure.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Hand hygiene
Hand washing...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

